Application of Heterocycles as an Alternative for the Discovery of New Anti-ulcer Compounds: A Mini-Review
Authors:
- Lucas Linhares de LócioLLLucas Linhares de Lócio
- Agnis Pâmela Simões Do NascimentoANAgnis Pâmela Simões Do Nascimento
- Mirelly Barbosa SantosMSMirelly Barbosa Santos
- Joilly Nilce Santana GomesJGJoilly Nilce Santana Gomes
- Yvnni Maria Sales de Medeiros e SilvaYSYvnni Maria Sales de Medeiros e Silva
- Sonaly Lima AlbinoSASonaly Lima Albino
- Vanda Lúcia dos SantosVSVanda Lúcia dos Santos
- Ricardo Olímpio de MouraRMRicardo Olímpio de Moura
- 1 May 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 28 (17) , 1373-1388
Abstract
A peptic ulcer is a lesion located in the esophagus, stomach, and upper intestine, caused by an imbalance between acid secretion and the release of protective mucus. This pathology is prevalent in approximately 14% of the world population and is commonly treated with proton pump inhibitors and type 2 histaminergic receptor antagonists, however, these drugs present concerning side effects that may lead to gastric cancer. In this sense, this research aimed to present the main heterocyclics studied in recent years. The screening method for the choice of articles was based on the selection of publications between 2000 and 2021 present in the Science Direct, Web of Science, Capes, and Scielo databases, by using the descriptors ''new derivatives'', “heterocyclics” “antiulcerogenic”, “gastroprotective” and “antisecretor”. This research showed that the most used rings in the development of anti-ulcer drugs were benzimidazole, quinazoline, thiazole, and thiadiazole. The results also portray several types of modern in silico, in vitro and in vivo assays, as well as the investigation of different mechanisms of action, with emphasis on proton pump inhibition, type 2 histaminergic receptor blockers, potassium competitive acid blockers, type E prostaglandin agonism, anti-secretory activity and anti-oxidant action. Additionally, the review evidenced the presence of the nitrogen atom in the heterocyclic ring as a determinant of the potential of the compound. This research suggests new alternatives for the treatment of gastric lesions, which may be more potent and cause fewer side effects than the currently used, and tend to evolve into more advanced studies in the coming years.Keywords
Funding Information
- Programa de Incentivo à Pós-Graduação e Pesquisa (4.03.00.00-5-388/2017-1)
- Fundação de Apoio à Pesquisa do Estado da Paraíba (013/2018)
This publication has 51 references indexed in Scilit:
- Synthesis and pharmacological evaluation of pyrazolopyrimidopyrimidine derivatives: anti-inflammatory agents with gastroprotective effect in ratsMedicinal Chemistry Research, 2013
- DL-trans-3,4-Dihydroxy-1-selenolane (DHSred) accelerates healing of indomethacin-induced stomach ulceration in miceFree Radical Research, 2012
- Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockersBioorganic & Medicinal Chemistry, 2012
- Phenoxypropylamines: Synthesis and Antiulcer EvaluationMolecules, 2009
- Spiro(imidazo[1,2-a]pyrano[2,3-c]pyridine-9-indenes) as inhibitors of gastric acid secretionBioorganic & Medicinal Chemistry, 2009
- Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chainBioorganic & Medicinal Chemistry Letters, 2008
- 5-Substituted 1H-pyrrolo[3,2-b]pyridines as inhibitors of gastric acid secretionBioorganic & Medicinal Chemistry, 2008
- Synthesis of pharmaceutically active compounds containing a disubstituted piperidine frameworkBioorganic & Medicinal Chemistry, 2008
- Preparation of tetrahydroimidazo[2,1-a]isoquinolines and their use as inhibitors of gastric acid secretionBioorganic & Medicinal Chemistry, 2007
- The effects of apigenin‐7‐O‐β‐d‐glucuronopyranoside on reflux oesophagitis and gastritis in ratsAutonomic & Autacoid Pharmacology, 2005